APO Research
Talk to an analyst

APO RESEARCH · REPORT

Azacitidine for Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Azacitidine for Injection Industry Growth and Trends Forecast to 2032

22 December 2025101 pages

Choose your research edition.

Industry ResearchAzacitidine for Injection Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Azacitidine for Injection Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Azacitidine for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Azacitidine for Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Azacitidine for Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Azacitidine for Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Azacitidine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Azacitidine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Azacitidine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Azacitidine for Injection include Chia Tai Tianqing Pharmaceutical, TEVA, Jiangsu Hansoh Pharmaceutical, Sichuan Huiyu Pharmaceutical, Viatris, Shilpa Medicare, Natco Pharma, Meitheal Pharmaceuticals and Lupin Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Azacitidine for Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Azacitidine for Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Azacitidine for Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Azacitidine for Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Azacitidine for Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Azacitidine for Injection Market by Company

Chia Tai Tianqing Pharmaceutical

TEVA

Jiangsu Hansoh Pharmaceutical

Sichuan Huiyu Pharmaceutical

Viatris

Shilpa Medicare

Natco Pharma

Meitheal Pharmaceuticals

Lupin Limited

Dr. Reddy's Laboratories

Cipla

Celgene

Amneal Pharmaceuticals

Accord Healthcare

Azacitidine for Injection Segment by Type

Original Drug

Generic Drug

Azacitidine for Injection Segment by Application

Hospitals

Clinics

Others

Azacitidine for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azacitidine for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Azacitidine for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azacitidine for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Azacitidine for Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Azacitidine for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Original Drug Table 2. Major Company of Generic Drug Table 3. Global Azacitidine for Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Azacitidine for Injection Sales by Type (2021-2026) & (k units) Table 5. Global Azacitidine for Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Azacitidine for Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Azacitidine for Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Azacitidine for Injection Price by Type (2021-2026) & (US$/unit) Table 9. Global Azacitidine for Injection Sales by Type (2027-2032) & (k units) Table 10. Global Azacitidine for Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Azacitidine for Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Azacitidine for Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Azacitidine for Injection Price by Type (2027-2032) & (US$/unit) Table 14. North America Azacitidine for Injection Sales by Type (2021-2026) & (k units) Table 15. North America Azacitidine for Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Azacitidine for Injection Sales by Type (2021-2026) & (k units) Table 17. Europe Azacitidine for Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Azacitidine for Injection Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Azacitidine for Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Azacitidine for Injection Sales by Type (2021-2026) & (k units) Table 21. Latin America Azacitidine for Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Azacitidine for Injection Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Azacitidine for Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Azacitidine for Injection Industry Trends Table 25. Azacitidine for Injection Industry Drivers Table 26. Azacitidine for Injection Industry Opportunities and Challenges Table 27. Azacitidine for Injection Industry Restraints Table 28. Global Azacitidine for Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Azacitidine for Injection Revenue Market Share by Company (2021-2026) Table 30. Global Azacitidine for Injection Sales by Company (2021-2026) & (k units) Table 31. Global Azacitidine for Injection Sales Share by Company (2021-2026) Table 32. Global Azacitidine for Injection Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Azacitidine for Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Azacitidine for Injection Major Company Production Sites and Headquarters Table 35. Global Azacitidine for Injection Company, Product Type & Application Table 36. Global Azacitidine for Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Azacitidine for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Azacitidine for Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Azacitidine for Injection Sales by Region (2021-2026) & (k units) Table 41. Global Azacitidine for Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Azacitidine for Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Azacitidine for Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Azacitidine for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Azacitidine for Injection Sales by Region (2027-2032) & (k units) Table 46. Global Azacitidine for Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Azacitidine for Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Azacitidine for Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Azacitidine for Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Azacitidine for Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Azacitidine for Injection Sales by Application (2021-2026) & (k units) Table 52. Global Azacitidine for Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Azacitidine for Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Azacitidine for Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Azacitidine for Injection Price by Application (2021-2026) & (US$/unit) Table 56. Global Azacitidine for Injection Sales by Application (2027-2032) & (k units) Table 57. Global Azacitidine for Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Azacitidine for Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Azacitidine for Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Azacitidine for Injection Price by Application (2027-2032) & (US$/unit) Table 61. North America Azacitidine for Injection Sales by Application (2021-2026) & (k units) Table 62. North America Azacitidine for Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Azacitidine for Injection Sales by Application (2021-2026) & (k units) Table 64. Europe Azacitidine for Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Azacitidine for Injection Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Azacitidine for Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Azacitidine for Injection Sales by Application (2021-2026) & (k units) Table 68. Latin America Azacitidine for Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Azacitidine for Injection Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Azacitidine for Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Chia Tai Tianqing Pharmaceutical Company Information Table 72. Chia Tai Tianqing Pharmaceutical Business Overview Table 73. Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Product Portfolio Table 75. Chia Tai Tianqing Pharmaceutical Recent Development Table 76. TEVA Company Information Table 77. TEVA Business Overview Table 78. TEVA Azacitidine for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. TEVA Azacitidine for Injection Product Portfolio Table 80. TEVA Recent Development Table 81. Jiangsu Hansoh Pharmaceutical Company Information Table 82. Jiangsu Hansoh Pharmaceutical Business Overview Table 83. Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Product Portfolio Table 85. Jiangsu Hansoh Pharmaceutical Recent Development Table 86. Sichuan Huiyu Pharmaceutical Company Information Table 87. Sichuan Huiyu Pharmaceutical Business Overview Table 88. Sichuan Huiyu Pharmaceutical Azacitidine for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Sichuan Huiyu Pharmaceutical Azacitidine for Injection Product Portfolio Table 90. Sichuan Huiyu Pharmaceutical Recent Development Table 91. Viatris Company Information Table 92. Viatris Business Overview Table 93. Viatris Azacitidine for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Viatris Azacitidine for Injection Product Portfolio Table 95. Viatris Recent Development Table 96. Shilpa Medicare Company Information Table 97. Shilpa Medicare Business Overview Table 98. Shilpa Medicare Azacitidine for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Shilpa Medicare Azacitidine for Injection Product Portfolio Table 100. Shilpa Medicare Recent Development Table 101. Natco Pharma Company Information Table 102. Natco Pharma Business Overview Table 103. Natco Pharma Azacitidine for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Natco Pharma Azacitidine for Injection Product Portfolio Table 105. Natco Pharma Recent Development Table 106. Meitheal Pharmaceuticals Company Information Table 107. Meitheal Pharmaceuticals Business Overview Table 108. Meitheal Pharmaceuticals Azacitidine for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Meitheal Pharmaceuticals Azacitidine for Injection Product Portfolio Table 110. Meitheal Pharmaceuticals Recent Development Table 111. Lupin Limited Company Information Table 112. Lupin Limited Business Overview Table 113. Lupin Limited Azacitidine for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Lupin Limited Azacitidine for Injection Product Portfolio Table 115. Lupin Limited Recent Development Table 116. Dr. Reddy's Laboratories Company Information Table 117. Dr. Reddy's Laboratories Business Overview Table 118. Dr. Reddy's Laboratories Azacitidine for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Dr. Reddy's Laboratories Azacitidine for Injection Product Portfolio Table 120. Dr. Reddy's Laboratories Recent Development Table 121. Cipla Company Information Table 122. Cipla Business Overview Table 123. Cipla Azacitidine for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Cipla Azacitidine for Injection Product Portfolio Table 125. Cipla Recent Development Table 126. Celgene Company Information Table 127. Celgene Business Overview Table 128. Celgene Azacitidine for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Celgene Azacitidine for Injection Product Portfolio Table 130. Celgene Recent Development Table 131. Amneal Pharmaceuticals Company Information Table 132. Amneal Pharmaceuticals Business Overview Table 133. Amneal Pharmaceuticals Azacitidine for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Amneal Pharmaceuticals Azacitidine for Injection Product Portfolio Table 135. Amneal Pharmaceuticals Recent Development Table 136. Accord Healthcare Company Information Table 137. Accord Healthcare Business Overview Table 138. Accord Healthcare Azacitidine for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Accord Healthcare Azacitidine for Injection Product Portfolio Table 140. Accord Healthcare Recent Development Table 141. North America Azacitidine for Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. North America Azacitidine for Injection Sales by Country (2021-2026) & (k units) Table 143. North America Azacitidine for Injection Sales Market Share by Country (2021-2026) Table 144. North America Azacitidine for Injection Sales Forecast by Country (2027-2032) & (k units) Table 145. North America Azacitidine for Injection Sales Market Share Forecast by Country (2027-2032) Table 146. North America Azacitidine for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Azacitidine for Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Azacitidine for Injection Market Share by Country (2021-2026) Table 149. North America Azacitidine for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Azacitidine for Injection Market Share Forecast by Country (2027-2032) Table 151. Europe Azacitidine for Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Europe Azacitidine for Injection Sales by Country (2021-2026) & (k units) Table 153. Europe Azacitidine for Injection Sales Market Share by Country (2021-2026) Table 154. Europe Azacitidine for Injection Sales Forecast by Country (2027-2032) & (k units) Table 155. Europe Azacitidine for Injection Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Azacitidine for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Azacitidine for Injection Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Azacitidine for Injection Market Share by Country (2021-2026) Table 159. Europe Azacitidine for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Azacitidine for Injection Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Azacitidine for Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Azacitidine for Injection Sales by Country (2021-2026) & (k units) Table 163. Asia-Pacific Azacitidine for Injection Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Azacitidine for Injection Sales Forecast by Country (2027-2032) & (k units) Table 165. Asia-Pacific Azacitidine for Injection Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Azacitidine for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Azacitidine for Injection Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Azacitidine for Injection Market Share by Country (2021-2026) Table 169. Asia-Pacific Azacitidine for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Azacitidine for Injection Market Share Forecast by Country (2027-2032) Table 171. Latin America Azacitidine for Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Latin America Azacitidine for Injection Sales by Country (2021-2026) & (k units) Table 173. Latin America Azacitidine for Injection Sales Market Share by Country (2021-2026) Table 174. Latin America Azacitidine for Injection Sales Forecast by Country (2027-2032) & (k units) Table 175. Latin America Azacitidine for Injection Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Azacitidine for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Azacitidine for Injection Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Azacitidine for Injection Market Share by Country (2021-2026) Table 179. Latin America Azacitidine for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Azacitidine for Injection Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Azacitidine for Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Azacitidine for Injection Sales by Country (2021-2026) & (k units) Table 183. Middle East and Africa Azacitidine for Injection Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Azacitidine for Injection Sales Forecast by Country (2027-2032) & (k units) Table 185. Middle East and Africa Azacitidine for Injection Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Azacitidine for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Azacitidine for Injection Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Azacitidine for Injection Market Share by Country (2021-2026) Table 189. Middle East and Africa Azacitidine for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Azacitidine for Injection Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Azacitidine for Injection Distributors List Table 194. Azacitidine for Injection Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Azacitidine for Injection Image Figure 2. Global Azacitidine for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Azacitidine for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Azacitidine for Injection Sales (2021-2032) & (k units) Figure 5. Original Drug Image Figure 6. Global Original Drug Sales YoY Growth (2021-2032) & (k units) Figure 7. Generic Drug Image Figure 8. Global Generic Drug Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Azacitidine for Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Azacitidine for Injection Market Share by Type 2025 VS 2032 Figure 11. North America Azacitidine for Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Azacitidine for Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Azacitidine for Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Azacitidine for Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Azacitidine for Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Azacitidine for Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Azacitidine for Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Azacitidine for Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Azacitidine for Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Azacitidine for Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Azacitidine for Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Image Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Azacitidine for Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Azacitidine for Injection Market Share by Application 2025 VS 2032 Figure 31. North America Azacitidine for Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Azacitidine for Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Azacitidine for Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Azacitidine for Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Azacitidine for Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Azacitidine for Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Azacitidine for Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Azacitidine for Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Azacitidine for Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Azacitidine for Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Azacitidine for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Azacitidine for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Azacitidine for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Azacitidine for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Azacitidine for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Azacitidine for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Azacitidine for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Azacitidine for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Azacitidine for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Azacitidine for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Azacitidine for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Azacitidine for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Azacitidine for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Azacitidine for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Azacitidine for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Azacitidine for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Azacitidine for Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Azacitidine for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Azacitidine for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Azacitidine for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Azacitidine for Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Azacitidine for Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Chia Tai Tianqing Pharmaceutical
  • TEVA
  • Jiangsu Hansoh Pharmaceutical
  • Sichuan Huiyu Pharmaceutical
  • Viatris
  • Shilpa Medicare
  • Natco Pharma
  • Meitheal Pharmaceuticals
  • Lupin Limited
  • Dr. Reddy's Laboratories
  • Cipla
  • Celgene
  • Amneal Pharmaceuticals
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Azacitidine for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Azacitidine for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Azacitidine for Injection Market by Type
  6. 1.3.1 Original Drug
  7. 1.3.2 Generic Drug
  8. 1.4 Global Azacitidine for Injection Market Size by Type
  9. 1.4.1 Global Azacitidine for Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Azacitidine for Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Azacitidine for Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Azacitidine for Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Azacitidine for Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Azacitidine for Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Azacitidine for Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Azacitidine for Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Azacitidine for Injection Industry Trends
  2. 2.2 Azacitidine for Injection Industry Drivers
  3. 2.3 Azacitidine for Injection Industry Opportunities and Challenges
  4. 2.4 Azacitidine for Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Azacitidine for Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Azacitidine for Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Azacitidine for Injection Price (2021-2026)
  4. 3.4 Global Azacitidine for Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Azacitidine for Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Azacitidine for Injection Company, Product Type & Application
  7. 3.7 Global Azacitidine for Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Azacitidine for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Azacitidine for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Azacitidine for Injection Tier 1, Tier 2, and Tier 3
4 Azacitidine for Injection Regional Status and Outlook
  1. 4.1 Global Azacitidine for Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Azacitidine for Injection Historic Market Size by Region
  3. 4.2.1 Global Azacitidine for Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Azacitidine for Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Azacitidine for Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Azacitidine for Injection Forecasted Market Size by Region
  7. 4.3.1 Global Azacitidine for Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Azacitidine for Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Azacitidine for Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Azacitidine for Injection by Application
  1. 5.1 Azacitidine for Injection Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Azacitidine for Injection Market Size by Application
  6. 5.2.1 Global Azacitidine for Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Azacitidine for Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Azacitidine for Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Azacitidine for Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Azacitidine for Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Azacitidine for Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Azacitidine for Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Azacitidine for Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chia Tai Tianqing Pharmaceutical
  2. 6.1.1 Chia Tai Tianqing Pharmaceutical Company Information
  3. 6.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
  4. 6.1.3 Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Product Portfolio
  6. 6.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
  7. 6.2 TEVA
  8. 6.2.1 TEVA Company Information
  9. 6.2.2 TEVA Business Overview
  10. 6.2.3 TEVA Azacitidine for Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 TEVA Azacitidine for Injection Product Portfolio
  12. 6.2.5 TEVA Recent Developments
  13. 6.3 Jiangsu Hansoh Pharmaceutical
  14. 6.3.1 Jiangsu Hansoh Pharmaceutical Company Information
  15. 6.3.2 Jiangsu Hansoh Pharmaceutical Business Overview
  16. 6.3.3 Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Product Portfolio
  18. 6.3.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  19. 6.4 Sichuan Huiyu Pharmaceutical
  20. 6.4.1 Sichuan Huiyu Pharmaceutical Company Information
  21. 6.4.2 Sichuan Huiyu Pharmaceutical Business Overview
  22. 6.4.3 Sichuan Huiyu Pharmaceutical Azacitidine for Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sichuan Huiyu Pharmaceutical Azacitidine for Injection Product Portfolio
  24. 6.4.5 Sichuan Huiyu Pharmaceutical Recent Developments
  25. 6.5 Viatris
  26. 6.5.1 Viatris Company Information
  27. 6.5.2 Viatris Business Overview
  28. 6.5.3 Viatris Azacitidine for Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Viatris Azacitidine for Injection Product Portfolio
  30. 6.5.5 Viatris Recent Developments
  31. 6.6 Shilpa Medicare
  32. 6.6.1 Shilpa Medicare Company Information
  33. 6.6.2 Shilpa Medicare Business Overview
  34. 6.6.3 Shilpa Medicare Azacitidine for Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shilpa Medicare Azacitidine for Injection Product Portfolio
  36. 6.6.5 Shilpa Medicare Recent Developments
  37. 6.7 Natco Pharma
  38. 6.7.1 Natco Pharma Company Information
  39. 6.7.2 Natco Pharma Business Overview
  40. 6.7.3 Natco Pharma Azacitidine for Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Natco Pharma Azacitidine for Injection Product Portfolio
  42. 6.7.5 Natco Pharma Recent Developments
  43. 6.8 Meitheal Pharmaceuticals
  44. 6.8.1 Meitheal Pharmaceuticals Company Information
  45. 6.8.2 Meitheal Pharmaceuticals Business Overview
  46. 6.8.3 Meitheal Pharmaceuticals Azacitidine for Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Meitheal Pharmaceuticals Azacitidine for Injection Product Portfolio
  48. 6.8.5 Meitheal Pharmaceuticals Recent Developments
  49. 6.9 Lupin Limited
  50. 6.9.1 Lupin Limited Company Information
  51. 6.9.2 Lupin Limited Business Overview
  52. 6.9.3 Lupin Limited Azacitidine for Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Lupin Limited Azacitidine for Injection Product Portfolio
  54. 6.9.5 Lupin Limited Recent Developments
  55. 6.10 Dr. Reddy's Laboratories
  56. 6.10.1 Dr. Reddy's Laboratories Company Information
  57. 6.10.2 Dr. Reddy's Laboratories Business Overview
  58. 6.10.3 Dr. Reddy's Laboratories Azacitidine for Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Dr. Reddy's Laboratories Azacitidine for Injection Product Portfolio
  60. 6.10.5 Dr. Reddy's Laboratories Recent Developments
  61. 6.11 Cipla
  62. 6.11.1 Cipla Company Information
  63. 6.11.2 Cipla Business Overview
  64. 6.11.3 Cipla Azacitidine for Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Cipla Azacitidine for Injection Product Portfolio
  66. 6.11.5 Cipla Recent Developments
  67. 6.12 Celgene
  68. 6.12.1 Celgene Company Information
  69. 6.12.2 Celgene Business Overview
  70. 6.12.3 Celgene Azacitidine for Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Celgene Azacitidine for Injection Product Portfolio
  72. 6.12.5 Celgene Recent Developments
  73. 6.13 Amneal Pharmaceuticals
  74. 6.13.1 Amneal Pharmaceuticals Company Information
  75. 6.13.2 Amneal Pharmaceuticals Business Overview
  76. 6.13.3 Amneal Pharmaceuticals Azacitidine for Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Amneal Pharmaceuticals Azacitidine for Injection Product Portfolio
  78. 6.13.5 Amneal Pharmaceuticals Recent Developments
  79. 6.14 Accord Healthcare
  80. 6.14.1 Accord Healthcare Company Information
  81. 6.14.2 Accord Healthcare Business Overview
  82. 6.14.3 Accord Healthcare Azacitidine for Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Accord Healthcare Azacitidine for Injection Product Portfolio
  84. 6.14.5 Accord Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Azacitidine for Injection Sales by Country
  2. 7.1.1 North America Azacitidine for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Azacitidine for Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Azacitidine for Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Azacitidine for Injection Market Size by Country
  6. 7.2.1 North America Azacitidine for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Azacitidine for Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Azacitidine for Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Azacitidine for Injection Sales by Country
  2. 8.1.1 Europe Azacitidine for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Azacitidine for Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Azacitidine for Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Azacitidine for Injection Market Size by Country
  6. 8.2.1 Europe Azacitidine for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Azacitidine for Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Azacitidine for Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Azacitidine for Injection Sales by Country
  2. 9.1.1 Asia-Pacific Azacitidine for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Azacitidine for Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Azacitidine for Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Azacitidine for Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Azacitidine for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Azacitidine for Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Azacitidine for Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Azacitidine for Injection Sales by Country
  2. 10.1.1 South America Azacitidine for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Azacitidine for Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Azacitidine for Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Azacitidine for Injection Market Size by Country
  6. 10.2.1 South America Azacitidine for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Azacitidine for Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Azacitidine for Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Azacitidine for Injection Sales by Country
  2. 11.1.1 Middle East and Africa Azacitidine for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Azacitidine for Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Azacitidine for Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Azacitidine for Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Azacitidine for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Azacitidine for Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Azacitidine for Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Azacitidine for Injection Value Chain Analysis
  2. 12.1.1 Azacitidine for Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Azacitidine for Injection Production Mode & Process
  7. 12.2 Azacitidine for Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Azacitidine for Injection Distributors
  10. 12.2.3 Azacitidine for Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst